Symbol
| ITGA7
| contributors: mct - updated : 21-03-2020
|
HGNC name
| integrin, alpha 7
|
HGNC id
| 6143
|
corresponding disease(s)
|
ITGA7D
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in Acute myeloid leukemia (AML) with granulocytic sarcoma (GS) | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| might serve as a potential biomarker for predicting increased AML risk and worse prognosis in AML patients | |
is a glioblastoma biomarker | |
prognostic factor in human Malignant pleural mesothelioma (MPM) | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | glioma/neuroblstoma | |
is a glioblastoma candidate therapeutic target (PMID: 28602620) | cancer | digestive | oesophagus | |
could be a potential therapeutic target in oesophageal squamous cell carcinoma treatment |
| | |
| alpha7 integrin null mices embryos exhibit vascular smooth muscle cell defects that result in cerebral vascular hemorrhaging |